Concepedia

Erik Hooijberg

EH

Statistics

Publications

81

Citations

4.8K

H-Index

39

Active since

1989

Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam(Current)

The Netherlands Cancer Institute

Oncode Institute

Vrije Universiteit Amsterdam

Erik Hooijberg is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in life sciences, immunology, and oncology.

ORCID

Publications per year

1989–2024

81

Publications

81

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial

Nick van Dijk, Alberto Gil-Jimenez, Karīna Siliņa et al. · Nature Medicine · 2020 · 397 citations · Full text

, , +11

Differential Effects of Notch Ligands Delta-1 and Jagged-1 in Human Lymphoid Differentiation

Ana C. Jaleco, Hélia Neves, Erik Hooijberg et al. · The Journal of Experimental Medicine · 2001 · 340 citations · Full text

, , +17

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

Joris L. Vos, Joris B.W. Elbers, Oscar Krijgsman et al. · Nature Communications · 2021 · 336 citations · Full text

, , +17

Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells

Wendy W. J. Unger, Astrid J. van Beelen, Sven C. M. Bruijns et al. · Journal of Controlled Release · 2012 · 179 citations

, , +16

Immortalization of Human CD8+ T Cell Clones by Ectopic Expression of Telomerase Reverse Transcriptase

Erik Hooijberg, Janneke J. Ruizendaal, Peter J.F. Snijders et al. · The Journal of Immunology · 2000 · 171 citations · Full text

, , +15

1–5 of 81